AI In Medical Diagnostics Market Report 2026

AI In Medical Diagnostics Market Overview

• AI In Medical Diagnostics market size has reached to $2.66 billion in 2025 • Expected to grow to $14.03 billion in 2030 at a compound annual growth rate (CAGR) of 38.7% • Growth Driver: Rising Investments In Healthcare Sector To Drive Market Growth • Market Trend: AI-Driven Primary Care Innovations Transforming Speed and Efficiency in Patient Diagnosis • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

The key promising market opportunities in the ai in medical diagnostics market include: • Software (Segmentation By Component) → Expected gain of $7933.29 Million • Hospitals (Segmentation By End User) → Expected gain of $6480.14 Million • Machine Learning (Segmentation By Technology) → Expected gain of $5986.62 Million

What Is Covered Under AI In Medical Diagnostics Market?

AI in medical diagnostics refers to the use of artificial intelligence in the treatment and medical diagnostics. AI in medical diagnostics is used for medical imaging data including X-rays, MRIs, ultrasounds, CT scans, and DXAs to help doctors discover and diagnose diseases more precisely and rapidly. The main components of AI in medical diagnostics are software and services. Software used in medical diagnostics may detect a variety of signs, such as the unexpected proliferation of molecules in cells that may be a sign of a disease, using picture processing. The technologies used in this process are natural language processing, computer vision, machine learning, context-aware computing, and others, that are used in special diagnostics cases such as brain and neurological, oncology, cardiac and vascular, chest and lung, obstetrics and gynecology, and others. These are applied through computer-aided detection, computer-aided diagnosis, quantitative analysis tools, and clinical decision, used by hospitals, diagnostics imaging centers, diagnostics laboratories, and others.

What Is The AI In Medical Diagnostics Market Growth Forecast?

The AI in medical diagnostics market size is expected to see exponential growth in the next few years. It will grow to $14.03 billion in 2030 at a compound annual growth rate (CAGR) of 38.7%. The growth in the forecast period can be attributed to rising adoption of AI imaging tools, increasing demand for faster diagnostics, growth of precision medicine, integration of AI with clinical systems, expansion of cloud-based diagnostics. Major trends in the forecast period include ai-based disease detection, computer-aided diagnostic systems, predictive diagnostic analytics, automation of diagnostic workflows, data-driven clinical insights.

What Is The Driver Of The AI In Medical Diagnostics Market?

The increasing investment in healthcare is expected to propel the growth of the AI in medical diagnostics market going forward. Health expenditure refers to the portion of total revenue that is spent by the public and private sectors for healthcare services. It provides employment for healthcare professionals, boosts earnings for healthcare employees, expands municipal tax revenues, and stimulates demand for associated goods and services that will support AI technology's application in healthcare. For instance, in November 2023, according to the Canadian Institute for Health Information, a Canada-based non-profit organization, total health expenditure is projected to reach $344 billion in 2023, reflecting a modest growth of 2.8% compared to the previous year. Therefore, the increasing investment in healthcare is driving the growth of the AI in medical diagnostics industry.

How Will The Drivers Impact Growth In The Global AI In Medical Diagnostics Market?

• Increasing Aging Population Worldwide (Low) – The increasing aging population worldwide will become a key driver of growth in the AI in medical diagnostics market by 2030. AI in medical diagnostics reduces healthcare costs by minimizing invasive procedures and lengthy processes. Early, accurate diagnoses decrease hospital stays and facility burdens, making healthcare more affordable and accessible for the elderly. Advances in AI, including machine learning and big data, enhance diagnostic tool capabilities, integrating seamlessly into healthcare systems. Continuous monitoring features in AI tools provide real-time data, enabling timely interventions for better chronic disease management. As a result, the increasing aging population worldwide is anticipated to contributing to annual growth in the market. • Rising Healthcare Expenditure Globally (Low) – The rising healthcare expenditure globally will emerge as a major factor driving the expansion of the AI in medical diagnostics market by 2030. Demand for affordable solutions is rising in tandem with rising healthcare expenses. Artificial intelligence (AI) simplifies procedures, minimizes pointless testing and maximizes resource utilization in medical diagnostics and improves decision-making and automating processes for effective healthcare delivery. Consequently, the rising healthcare expenditure globally is projected to contributing to annual growth in the market. • Favorable Government Initiatives (Low) – The favorable government initiatives within digital manufacturing processes will serve as a key growth catalyst for the AI in medical diagnostics market by 2030. Governments globally are developing policies to enhance AI integration in healthcare, positively impacting AI in medical diagnostics industry. Additionally, countries are streamlining regulatory processes and fostering public-private partnerships to promote innovation. Therefore, this favorable government initiatives is projected to supporting to annual growth in the market. • Shortage Of Skilled Healthcare Professionals (Low) – The shortage of skilled healthcare professionals will become a significant driver contributing to the growth of the AI in medical diagnostics market by 2030. AI-driven diagnostic tools automate routine tasks, allowing healthcare professionals to focus on complex cases and provide timely care. Artificial intelligence (AI) algorithms aid clinical decision-making by interpreting complex data and enhancing efficiency and accuracy. Leveraging machine learning, AI improves diagnostic accuracy, reducing errors and unnecessary follow-ups, especially in resource-scarce settings. Consequently, the shortage of skilled healthcare professionals is projected to contributing to annual growth in the market.

How Will The Restraints Impact Growth In The Global AI In Medical Diagnostics Market?

• High Procurement Cost Of AI Systems (Low) – High Procurement Cost Of AI Systems will restrict the growth of the AI In Medical Diagnostics market during the forecast period. AI diagnostic systems involve significant costs for software, hardware, integration, and training. The high upfront investment and ongoing maintenance costs create financial barriers for smaller healthcare facilities and those in developing regions. Cost constraints can limit the adoption of AI diagnostic solutions, particularly in budget-constrained healthcare systems.

Key Players In The Global AI In Medical Diagnostics Market

Major companies operating in the AI in medical diagnostics market are International Business Machines Corporation; Siemens Healthineers AG; GE HealthCare Technologies Inc.; Digital Diagnostics Inc.; Heartflow Inc.; Aidoc Medical Ltd.; Koninklijke Philips N.V.; Nanox Imaging Ltd.; Enlitic Inc.; Aidence B.V.; Butterfly Network Inc.; Day Zero Diagnostics Inc.; Arterys Inc.; PathAI Inc.; Zebra Medical Vision Inc.; Caption Health Inc.; Proscia Inc.; AliveCor Corporation; ResApp Health Limited; Volpara Health Technologies Limited

Global AI In Medical Diagnostics Market Trends and Insights

Major companies operating in the AI in medical diagnostics market are focusing on developing advanced solutions such as digital pod-based primary care platforms to enhance patient experience and operational efficiency. Digital pod-based primary care platforms are modular clinics that integrate AI-driven consultations, diagnostics, testing, and medication dispensing into a seamless workflow delivering rapid care. For instance, in November 2024, Forte Healthcare, a UAE-based healthcare company, launched MediBAY, featuring an AI-powered clinic model that enables patients to complete their entire healthcare journey in under 30 minutes. Key features of the launched product include AI-based consultations, testing, diagnostics and medication dispensing through digital pods tailored for immediate care demand; multilingual live tele-consultations with physicians and trained nurses supporting streamlined patient flow; blockchain-enabled safety and compliance alongside integration of patient records diagnostics and prescriptions into a unified system; a design that reduces load on general practitioners and hospital facilities by improving access and quality of primary care; and advanced AI, robotics and automation developed in collaboration with academic and industry experts to set new digital healthcare standards.

What Are Latest Mergers And Acquisitions In The AI In Medical Diagnostics Market?

In October 2024, GE HealthCare Technologies Inc., a US-based medical technology company, acquired Intelligent Ultrasound Group PLC for approximately $53 million. With this acquisition, GE HealthCare aims to integrate Intelligent Ultrasound's AI-driven tools into its ultrasound portfolio to enhance workflow efficiency, reduce repetitive tasks, and simplify ultrasound exams for clinicians. Intelligent Ultrasound Group PLC is a UK-based diagnostics company that specializes in AI-driven ultrasound software and training tools for medical diagnostics.

What Defines the AI In Medical Diagnostics Market?

The AI in medical diagnostics market consists of revenues earned by entities by providing services such as magnetic resonance imaging (MRI), ultrasound, and computed tomography scans, robotic process automation, machine learning, natural language processing, and rule-based expert systems. The market value includes the value of related goods sold by the service provider or included within the service offering. AI in the medical diagnostics market also includes sales of dental devices, diabetes care devices, nephrology and urology devices, neurology devices, and physical robots which are used in providing AI in medical diagnostics services. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the AI In Medical Diagnostics Market Report 2026?

The ai in medical diagnostics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the ai in medical diagnostics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.